Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2018 May 2

PMID 29710776

Citations 15

Authors

Jenna Kitz

Lori E Lowes

David Goodale

Alison L Allan

Affiliations

Soon will be listed here.

Abstract

The majority of cancer deaths occur because of metastasis since current therapies are largely non-curative in the metastatic setting. The use of in vivo preclinical mouse models for assessing metastasis is, therefore, critical for developing effective new cancer biomarkers and therapies. Although a number of quantitative tools have been previously developed to study in vivo metastasis, the detection and quantification of rare metastatic events has remained challenging. This review will discuss the use of circulating tumor cell (CTC) analysis as an effective means of tracking and characterizing metastatic disease progression in preclinical mouse models of breast and prostate cancer and the resulting lessons learned about CTC and metastasis biology. We will also discuss how the use of clinically-relevant CTC technologies such as the CellSearch and Parsortix™ platforms for preclinical CTC studies can serve to enhance the study of cancer biology, new biomarkers, and novel therapies from the bench to the bedside.

Citing Articles

Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.

Seyhan A Int J Mol Sci. 2024; 25(14).

PMID: 39063215 PMC: 11277426. DOI: 10.3390/ijms25147974.

Liquid biopsy: creating opportunities in brain space.

Trivedi R, Bhat K Br J Cancer. 2023; 129(11):1727-1746.

PMID: 37752289 PMC: 10667495. DOI: 10.1038/s41416-023-02446-0.

Technologies for Viable Circulating Tumor Cell Isolation.

Tretyakova M, Menyailo M, Schegoleva A, Bokova U, Larionova I, Denisov E Int J Mol Sci. 2022; 23(24).

PMID: 36555625 PMC: 9788311. DOI: 10.3390/ijms232415979.

Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy.

Stamatakis K, Torres-Gerica P, Jimenez-Segovia A, Ramos-Munoz E, Crespo-Toro L, Fuentes P Front Pharmacol. 2022; 12:806395.

PMID: 35153760 PMC: 8831911. DOI: 10.3389/fphar.2021.806395.

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers.

Holcakova J, Bartosik M, Anton M, Minar L, Hausnerova J, Bednarikova M Cancers (Basel). 2021; 13(24).

PMID: 34944963 PMC: 8699592. DOI: 10.3390/cancers13246339.

References

Peeters D, De Laere B, Van den Eynden G, Van Laere S, Rothe F, Ignatiadis M . Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br J Cancer. 2013; 108(6):1358-67. PMC: 3619252. DOI: 10.1038/bjc.2013.92. View

Choi E, Oh J, Chung Y . Herpes Zoster Mimicking Breast Cancer With Axillary Lymph Node Metastasis on PET/CT. Clin Nucl Med. 2015; 40(7):572-3. DOI: 10.1097/RLU.0000000000000804. View

Vargas H, Schor-Bardach R, Long N, Kirzner A, Cunningham J, Goldman D . Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdom Radiol (NY). 2016; 42(1):271-277. PMC: 5247358. DOI: 10.1007/s00261-016-0851-3. View

Lowes L, Allan A . Recent advances in the molecular characterization of circulating tumor cells. Cancers (Basel). 2014; 6(1):595-624. PMC: 3980613. DOI: 10.3390/cancers6010595. View

Yu M, Stott S, Toner M, Maheswaran S, Haber D . Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011; 192(3):373-82. PMC: 3101098. DOI: 10.1083/jcb.201010021. View

Marrinucci D, Bethel K, Kolatkar A, Luttgen M, Malchiodi M, Baehring F . Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol. 2012; 9(1):016003. PMC: 3387996. DOI: 10.1088/1478-3975/9/1/016003. View

Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat S, Kim S . Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. Prostate. 2013; 74(2):210-6. DOI: 10.1002/pros.22742. View

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

Li M, Lu H, Gao Y . FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images. Clin Nucl Med. 2013; 38(11):916-8. DOI: 10.1097/RLU.0b013e3182a757fd. View

10.

Giovanella L, Castellani M, Suriano S, Ruberto T, Ceriani L, Tagliabue L . Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer. Tumori. 2011; 97(5):629-33. DOI: 10.1177/030089161109700515. View

11.

Sanches P, Peters S, Rossin R, Kaijzel E, Que I, Lowik C . Bone metastasis imaging with SPECT/CT/MRI: a preclinical toolbox for therapy studies. Bone. 2015; 75:62-71. DOI: 10.1016/j.bone.2015.02.002. View

12.

Kang Y, Pantel K . Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013; 23(5):573-81. PMC: 3667710. DOI: 10.1016/j.ccr.2013.04.017. View

13.

Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H . Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med. 2004; 45(2):272-8. View

14.

Shen G, Deng H, Hu S, Jia Z . Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014; 43(11):1503-13. DOI: 10.1007/s00256-014-1903-9. View

15.

Roodman G . Mechanisms of bone metastasis. N Engl J Med. 2004; 350(16):1655-64. DOI: 10.1056/NEJMra030831. View

16.

Alunni-Fabbroni M, Sandri M . Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods. 2010; 50(4):289-97. DOI: 10.1016/j.ymeth.2010.01.027. View

17.

Lin C, Luciani A, Itti E, Haioun C, Rahmouni A . Whole body MRI and PET/CT in haematological malignancies. Cancer Imaging. 2007; 7 Spec No A:S88-93. PMC: 2727965. DOI: 10.1102/1470-7330.2007.9004. View

18.

Mehlen P, Puisieux A . Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6(6):449-58. DOI: 10.1038/nrc1886. View

19.

OConnor J, Aboagye E, Adams J, Aerts H, Barrington S, Beer A . Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2016; 14(3):169-186. PMC: 5378302. DOI: 10.1038/nrclinonc.2016.162. View

20.

Lianidou E, Markou A . Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem. 2011; 57(9):1242-55. DOI: 10.1373/clinchem.2011.165068. View